sees qtr-two adjusted earnings per share $num-one to $num - two excluding items.
qtr-one earnings per share $num-one.
qtrly core sales increased num-one% compared to qtr-two year-five.
compname reports qtr-two earnings per share $num-two.
qtr-one sales rose num-one percent to $num-one billion.
qtr-one adjusted earnings per share $num-two excluding items.
compname announces num-one% increase in quarterly dividend and $num-one billion share repurchase authorization.
sees fy year-six capital expenditures $num-one million to $2.0 billion.
qtrly core sales to beauty market decrease num-one% due to continued localized lockdowns, especially in europe, and global travel restrictions, which have caused a significant reduction in traditional retail sales.
qtrly net sales rose num-one percent to $4.0 billion.
qtrly core sales to the prescription market decreased num-one%.
qtrly core sales increased num-one% to $num-one billion.
qtrly core sales to consumer healthcare market decreased num-one% for reasons that stephan mentioned earlier.
qtrly total segment core sales of $num-one billion, up num-one%.
sees qtr-two year-six earnings per share growth of num-one% to num-two%.
qtrly core sales of active material science solutions increased num-one%.
